Imlunestrant improved PFS in ESR1-mutated breast cancer compared to standard endocrine therapy, but not significantly in the overall population. Combining imlunestrant with Verzenio enhanced PFS in ...
Prognostic effects of co-occurring TP53 and KRAS aberrations in patients with advanced biliary tract cancer.
Breast cancer treatment has been a showcase of increasing precision—from surgery and chemotherapy, to endocrine therapies and targeted treatments. Breast cancer subtypes can be defined by expression ...
image: Mafalda Oliveira, Senior Consultant at the Vall d’Hebron University Hospital’s Medical Oncology Department and Clinical Investigator of the Vall d’Hebron Institute of Oncology’s (VHIO) Breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results